News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Israel-Based Clearmind Medicine Announces First Clinical Center to Join Its Clinical Trial for Alcohol Use Disorder
Thursday, December 29, 2022Clearmind Medicine Inc a biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
Friday, December 23, 2022BioNTech SE and Shanghai Fosun Pharmaceutical Group Co Ltd announced that the companies provided approximately doses of mRNAbased COVID vaccines which arrived on the Chinese Mainland on December The delivery contains both the companies Omicron BA...
OKYO Pharma Announces U.S. FDA Clearance of IND Application for OK-101 for the Treatment of Dry Eye Disease
Friday, December 23, 2022OKYO Pharma Limited an ophthalmologyfocused biopharmaceutical company developing OK to treat dry eye disease DED to address the significant unmet need in this multibilliondollar market today announced that it has received clearance of its Investigati...
BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163
Thursday, December 22, 2022BioNTech SE announced that the first subject was dosed in a firstinhuman Phase clinical research study with BNT a herpes simplex virus HSV vaccine candidate for the prevention of genital lesions caused by HSV and potentially HSV The trial NCT will e...
Cosmo And Hyphens Announce Signing Of License And Supply Agreements For Winlevi® In Southeast Asia
Thursday, December 22, 2022Cosmo Pharmaceuticals NV and Hyphens Pharma International Limited announced the signing of License and Supply Agreements for Winlevi clascoterone cream in Southeast Asia Under the terms of the agreements Hyphens Pharma Pte Ltd a subsidiary of Hyphen...
KKR to Acquire Bushu Pharmaceuticals
Wednesday, December 21, 2022KKR a leading global investment firm and Bushu Pharmaceuticals Ltd Bushu Pharma or the Company today announced the signing of definitive agreements under which KKR will acquire all shares in Bushu Pharma from BPEA EQT Following the transactions compl...
Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD
Wednesday, December 21, 2022Abivax SA a Phase clinicalstage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic inflammatory diseases today announced that the US Food and Drug Administration the FDA provided t...
Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia
Tuesday, December 20, 2022Boehringer Ingelheim and Click Therapeutics today announced the launch of an expanded collaboration for the development and commercialization of a second prescriptionbased digital therapeutic PDT The companies will collaborate to develop and commerci...
Biocytogen Announces FDA Clearance of IND Application for Bispecific Antibody YH008
Tuesday, December 20, 2022Biocytogen Pharmaceuticals Beijing Co Ltd announced that the US FDA has approved the Investigational New Drug IND application for a phase I study of YH an
Reviva Pharmaceuticals Announces Positive Safety Data from Drug-Drug Interaction Clinical Study of Brilaroxazine
Friday, December 16, 2022Reviva Pharmaceuticals Holdings Inc a clinicalstage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system CNS cardiovascular metabolic and inflammatory diseases today announced pos...
